Literature DB >> 25070942

Can mass drug administration lead to the sustainable control of schistosomiasis?

Allen G P Ross1, Remigio M Olveda2, Delia Chy3, David U Olveda1, Yuesheng Li4, Donald A Harn5, Darren J Gray6, Donald P McManus3, Veronica Tallo2, Thao N P Chau7, Gail M Williams6.   

Abstract

BACKGROUND: In the Philippines, the current national control strategy for schistosomiasis is annual mass drug administration (MDA) with 40 mg/kg of praziquantel in all schistosomiasis-endemic villages with a prevalence ≥10%.
METHODS: A cross-sectional survey of schistosomiasis was conducted in 2012 on 18 221 individuals residing in 22 schistosomiasis-endemic villages in the province of Northern Samar. The prevalence of schistosomiasis, intensity of Schistosoma infection, and morbidity of disease were assessed.
RESULTS: Despite an active schistosomiasis-control program in Northern Samar for >30 years, which included a MDA campaign in the last 5 years, the mean prevalence of schistosomiasis among 10 435 evaluated subjects was 27.1% (95% confidence interval [CI], 26.3%-28.0%), and the geometric mean intensity of infection among 2832 evaluated subjects was 17.2 eggs per gram of feces (95% CI, 16.4-18.1). Ultrasonography revealed high levels of schistosomiasis-induced morbidity in the schistosomiasis-endemic communities. Left lobe liver enlargement (≥70 mm) was evident in 89.3% of subjects. Twenty-five percent of the study population had grade II/III liver parenchyma fibrosis, and 13.3% had splenomegaly (≥100 mm).
CONCLUSIONS: MDA on its own was insufficient to control the prevalence of schistosomiasis, intensity of Schistosoma infection, or morbidity of the disease. Alternative control measures will be needed to complement the existing national MDA program.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  control; elimination; mass drug administration (MDA); schistosomiasis

Mesh:

Substances:

Year:  2014        PMID: 25070942     DOI: 10.1093/infdis/jiu416

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Something old, something new: is praziquantel enough for schistosomiasis control?

Authors:  W Evan Secor; Susan P Montgomery
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

2.  Mass Drug Administration of Triclabendazole for Fasciola Hepatica in Bolivia.

Authors:  Sergio Mollinedo; Patricia Gutierrez; Rosa Azurduy; Freddy Valle; Alejandra Salas; Zoraida Mollinedo; Paula Soto; Cleye F Villarroel; Janet Ransom; Robb Lawrence; Jonathan Berman; Jaime Soto
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

3.  Long-term effectiveness of the integrated schistosomiasis control strategy with emphasis on infectious source control in China: a 10-year evaluation from 2005 to 2014.

Authors:  Xiaoli Wang; Wei Wang; Peng Wang
Journal:  Parasitol Res       Date:  2016-11-03       Impact factor: 2.289

4.  Patient journey and resources mapping to implement a praziquantel mass drug administration program for children aged 5 years and below in resource-limited settings.

Authors:  Mhlengi Vella Ncube; Muhubiri Kabuyaya; Moses John Chimbari
Journal:  Syst Rev       Date:  2022-10-21

Review 5.  Advances in the Diagnosis of Human Schistosomiasis.

Authors:  Kosala G A D Weerakoon; Geoffrey N Gobert; Pengfei Cai; Donald P McManus
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 6.  Neglected tropical diseases among the Association of Southeast Asian Nations (ASEAN): overview and update.

Authors:  Peter J Hotez; Maria Elena Bottazzi; Ulrich Strych; Li-Yen Chang; Yvonne A L Lim; Maureen M Goodenow; Sazaly AbuBakar
Journal:  PLoS Negl Trop Dis       Date:  2015-04-16

7.  Relative compatibility of Schistosoma mansoni with Biomphalaria sudanica and B. pfeifferi from Kenya as assessed by PCR amplification of the S. mansoni ND5 gene in conjunction with traditional methods.

Authors:  Lijun Lu; Si-Ming Zhang; Martin W Mutuku; Gerald M Mkoji; Eric S Loker
Journal:  Parasit Vectors       Date:  2016-03-21       Impact factor: 3.876

8.  Editorial: The Schistosomiasis Vaccine - It is Time to Stand up.

Authors:  Rashika El Ridi; Ahmad A Othman; Donald P McManus
Journal:  Front Immunol       Date:  2015-07-30       Impact factor: 7.561

9.  Knowledge, attitude, and practices towards schistosomiasis among rural population in Yemen.

Authors:  Hany Sady; Hesham M Al-Mekhlafi; Wahib M Atroosh; Ahmed K Al-Delaimy; Nabil A Nasr; Salwa Dawaki; Mona A Al-Areeqi; Init Ithoi; Awatif M Abdulsalam; Kek Heng Chua; Johari Surin
Journal:  Parasit Vectors       Date:  2015-08-25       Impact factor: 3.876

Review 10.  Systematic Review and Meta-analysis of the Impact of Chemical-Based Mollusciciding for Control of Schistosoma mansoni and S. haematobium Transmission.

Authors:  Charles H King; Laura J Sutherland; David Bertsch
Journal:  PLoS Negl Trop Dis       Date:  2015-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.